Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Integrated analysis of controlled clinical trials evaluating efficacy and safety of sofosbuvir-based regimens in chronic hepatitis C genotype 6 (HCV GT 6) Proceeding/Conference:Journal of Hepatology | 2017 | ||
Sofosbuvir plus ribavirin for 12 16 or 24 weeks results in sustained virologic response over 97% in genotype 1 and 6 HCV infection in Hong Kong Proceeding/Conference:Hepatology International | 2015 | ||
2017 |